» Articles » PMID: 35741796

Differentially Expressed MiRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2022 Jun 24
PMID 35741796
Authors
Affiliations
Soon will be listed here.
Abstract

To date, no neurodegenerative diseases (NDDs) have cures, and the underlying mechanism of their pathogenesis is undetermined. As miRNAs extensively regulate all biological processes and are crucial regulators of healthy brain function, miRNAs differentially expressed in NDDs may provide insight into the factors that contribute to the emergence of protein inclusions and the propagation of deleterious cellular environments. A meta-analysis of miRNAs dysregulated in Alzheimer's disease, Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies and frontotemporal lobar degeneration (TDP43 variant) was performed to determine if diseases within a proteinopathy have distinct or shared mechanisms of action leading to neuronal death, and if proteinopathies can be classified on the basis of their miRNA profiles. Our results identified both miRNAs distinct to the anatomy, disease type and pathology, and miRNAs consistently dysregulated within single proteinopathies and across neurodegeneration in general. Our results also highlight the necessity to minimize the variability between studies. These findings showcase the need for more transcriptomic research on infrequently occurring NDDs, and the need for the standardization of research techniques and platforms utilized across labs and diseases.

Citing Articles

Epigenetic Modifications Associated With Wildland-Urban Interface (WUI) Firefighting.

Goodrich J, Furlong M, Urwin D, Gabriel J, Hughes J, Jung A Environ Mol Mutagen. 2025; 66(1-2):22-33.

PMID: 39968828 PMC: 11905879. DOI: 10.1002/em.70002.


Cerebellar Micro-RNA Profile in a Mouse Model of Spinocerebellar Ataxia Type 2.

Paul S, Dansithong W, Gandelman M, Figueroa K, Scoles D, Pulst S Neurol Genet. 2024; 10(2):e200144.

PMID: 38715656 PMC: 11073881. DOI: 10.1212/NXG.0000000000200144.


Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP.

Olah J, Norris V, Lehotzky A, Ovadi J Cells. 2024; 13(4.

PMID: 38391951 PMC: 10886726. DOI: 10.3390/cells13040338.


Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis.

Ben Patel R, Bajpai A, Thirumurugan K J Mol Neurosci. 2023; 73(6):375-390.

PMID: 37249795 DOI: 10.1007/s12031-023-02124-z.

References
1.
Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y . Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008; 64(1):60-70. PMC: 2674108. DOI: 10.1002/ana.21425. View

2.
Broughton J, Lovci M, Huang J, Yeo G, Pasquinelli A . Pairing beyond the Seed Supports MicroRNA Targeting Specificity. Mol Cell. 2016; 64(2):320-333. PMC: 5074850. DOI: 10.1016/j.molcel.2016.09.004. View

3.
Prasansuklab A, Tencomnao T . Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy. Evid Based Complement Alternat Med. 2013; 2013:413808. PMC: 3671299. DOI: 10.1155/2013/413808. View

4.
Patrick E, Rajagopal S, Wong H, McCabe C, Xu J, Tang A . Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017; 12(1):51. PMC: 5494142. DOI: 10.1186/s13024-017-0191-y. View

5.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View